Cas 943314-75-8,2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester

943314-75-8

Post Buying Request

Basic information

Product Name: 2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester
Synonyms: 2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester
CAS NO:943314-75-8
Molecular Formula:
Molecular Weight: 426.429
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester(943314-75-8)
EPA Substance Registry System: 2-[6-(3-tert-butoxycarbonylamino-phenoxy)-pyrimidin-4-yl]-oxazole-4-carboxylic acid ethyl ester(943314-75-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 943314-75-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

943314-75-8 Suppliers

Recommended suppliers

943314-75-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 943314-75-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,3,1 and 4 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 943314-75:
(8*9)+(7*4)+(6*3)+(5*3)+(4*1)+(3*4)+(2*7)+(1*5)=168
168 % 10 = 8
So 943314-75-8 is a valid CAS Registry Number.

943314-75-8Upstream product

943314-75-8Downstream Products

943314-75-8Relevant academic research and scientific papers

NOVEL SUBSTITUTED PYRIMIDINYLOXY UREAS USEFUL AS INHIBITORS OF PROTEIN KINASES

-

Page/Page column 82, (2010/11/27)

The present invention relates to compounds and methods useful as inhibitors of protein kinases, including B-Raf and several receptor tyrosine and cytoplasmic tyrosine kinases. The present invention is directed to new substituted pyrimidinyloxy urea compounds of Formulas II, III and IV and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulating of protein kinase activity in a human or animal subject are also provided for the treatment diseases such as cancers.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 943314-75-8